FR Pharma Consulting ApS: Financial statements 2026
CVR: 44253569
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
FR Pharma Consulting ApS (CVR 44253569) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 424,639 and a net result of DKK -336,968 compared with DKK 654,878 the year before. That is a decrease of 72.9% compared with the year before. Equity in the 2026 report amounted to DKK 561,263. The solvency ratio was 73%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 424,639
- Profit/Loss
- DKK -336,968
- Equity
- DKK 561,263
- Total Assets
- DKK 769,270
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 425K | -337K | 561K | 1 |
| 2025 | - | 1.6M | 655K | 898K | 1 |
| 2024 | - | 750K | 203K | 243K | 1 |
Official annual report
Find more companies like FR Pharma Consulting ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout FR Pharma Consulting ApS
FR Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2023. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Ferhat Celik. The company is owned by FR Pharma ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK 424,639 and a net result of DKK -336,968 compared with DKK 654,878 the year before. Equity in the 2026 report amounted to DKK 561,263.